Last reviewed · How we verify
The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines
To Confirm the non-inferiority of CUNOX® to BOTOX® in the glabellar line improvement of moderate to severe glabellar lines.
Details
| Lead sponsor | Medy-Tox |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 136 |
| Start date | Thu Dec 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Jun 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Glabellar Frown Lines
Interventions
- Cunox
- Botox
Countries
Russia